← Back to Search

Robotic Surgery

Robotic-Assisted Knee Replacement for Osteoarthritis

N/A
Recruiting
Led By Herbert John Cooper, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Failure of a minimum 12 weeks of nonoperative management
End-stage knee osteoarthritis (Kellgren and Lawrence grade 4)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

This trial will compare outcomes of robotic-assisted versus conventional total knee replacement surgery in patients with end stage arthritis of the knee.

Who is the study for?
This trial is for individuals aged 40-85 with severe knee osteoarthritis who haven't improved after at least 12 weeks of non-surgical treatment. Participants must have a BMI under 40, speak English fluently, and not have had previous open knee surgery or other major knee issues.Check my eligibility
What is being tested?
The study compares robotic-assisted total knee replacement using the Navio system to conventional surgery. Both groups receive identical care and implants but differ in surgical technique. Patients will undergo x-rays and complete tests to assess their surgery's success.See study design
What are the potential side effects?
While specific side effects are not listed for the Navio system, typical risks of knee replacement include pain, swelling, infection risk at the incision site, blood clots, implant problems like loosening or wear, and possible need for additional surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have tried non-surgical treatments for 12 weeks without improvement.
Select...
My knee pain is due to the most severe stage of arthritis.
Select...
I am between 40 and 85 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Erythrocyte Indices
Score on the Timed Up and Go Test (TUG)
Secondary outcome measures
Score on Global Rating Score of Knee Function (GRS)
Score on New Knee Society Scores (2011 KSS)
Score on Short-Form 12 Health Questionnaire (SF-12)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Navio™ Robotics-assisted Surgical SystemExperimental Treatment1 Intervention
Navio™ Robotics-assisted Surgical System
Group II: Non robotics-assisted Surgical SystemActive Control1 Intervention
Conventional, non-robotics-assisted total knee surgical system

Find a Location

Who is running the clinical trial?

Smith & Nephew, Inc.Industry Sponsor
165 Previous Clinical Trials
22,381 Total Patients Enrolled
32 Trials studying Osteoarthritis
4,638 Patients Enrolled for Osteoarthritis
Columbia UniversityLead Sponsor
1,439 Previous Clinical Trials
2,447,658 Total Patients Enrolled
6 Trials studying Osteoarthritis
1,025 Patients Enrolled for Osteoarthritis
Herbert John Cooper, MDPrincipal Investigator - Columbia University
Lenox Hill Hospital
Medical School - Columbia University, Doctor of Medicine
Lenox Hill Hospital, Residency in Orthopedic Surgery

Media Library

Navio™ Robotics-assisted Surgical System (Robotic Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT03519269 — N/A
Osteoarthritis Research Study Groups: Navio™ Robotics-assisted Surgical System, Non robotics-assisted Surgical System
Osteoarthritis Clinical Trial 2023: Navio™ Robotics-assisted Surgical System Highlights & Side Effects. Trial Name: NCT03519269 — N/A
Navio™ Robotics-assisted Surgical System (Robotic Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03519269 — N/A
~19 spots leftby Dec 2025